During the 1990s and early 2000s, Europe experienced a significant increase in occupational asthma cases that was traced directly to indoor polyurethane coating applications. Construction painters, who applied isocyanate-containing floor coatings, sealants, and varnishes in enclosed spaces, showed the highest asthma rate among all construction trades. This epidemic provides a cautionary tale about the dangers of applying reactive chemical coatings in poorly ventilated indoor environments - and a powerful argument for specifying safer alternatives.

Multiple European countries documented simultaneous increases in isocyanate asthma:

The European Asthma Epidemic: Isocyanates from Indoor Coating Applications

The European Experience

The Epidemic Pattern

• Sweden: Sharp increase in occupational asthma among painters and floor layers
• Finland: Construction trades showed disproportionate asthma burden
• United Kingdom: Isocyanate asthma became the leading cause of occupational asthma
• Germany: Polyurethane coating workers overrepresented in asthma registries
• Denmark: Similar patterns in construction and manufacturing

The Common Factor

The epidemic coincided with the widespread adoption of two-component polyurethane coatings for:

• Floor finishing (wood, concrete, epoxy-polyurethane hybrids)
• Wood varnishes and clearcoats
• Concrete sealers and topcoats
• Automotive refinish (particularly problematic in body shops)

These coatings offered excellent durability, chemical resistance, and aesthetic properties. But they required isocyanate-containing hardeners - and were frequently applied indoors with inadequate ventilation.

Construction Painters: The Highest-Risk Trade

European occupational health surveillance consistently identified construction painters as having the highest asthma rates among all trades:

The painter's elevated risk reflected the combination of:

1. Isocyanate exposure: From polyurethane coatings
2. Solvent exposure: From paint thinners and reducers
3. Indoor application: Confined spaces with poor ventilation
4. Respirable aerosols: Spray application generates fine droplets
5. Peak exposures: Short periods of high concentration during application

Why Indoor Application Is Especially Dangerous

Ventilation Limitations

Indoor spaces inherently limit ventilation:

• Natural ventilation is minimal in enclosed buildings
• Mechanical ventilation is often inadequate or absent
• Recirculating air systems distribute contaminants throughout buildings
• Negative pressure is difficult to maintain in occupied structures

Concentration Build-Up

VOCs and isocyanates accumulate in enclosed spaces:

• Application period: Concentrations peak during active spraying
• Curing period: Continued off-gassing for hours to days
• Re-entry period: Workers return to spaces with residual vapors

Proximity to Application

Indoor workers cannot maintain distance from the coating operation:

• Same room: Other trades work in adjacent areas
• HVAC distribution: Building air systems spread contaminants
• Surface contact: Workers touch freshly coated surfaces

The Regulatory Response

European countries responded with various regulatory measures:

Sweden's Approach

• Restricted isocyanate-containing products for indoor use
• Required professional applicator training and certification
• Mandated ventilation standards for coating work

UK HSE Guidance

• Published detailed guidance on isocyanate control
• Required medical surveillance for exposed workers
• Emphasized substitution with less hazardous materials

EU-Wide Measures

• REACH regulations require isocyanate safety training
• CLP classification mandates hazard communication
• Some member states imposed additional restrictions

Limitations of the Regulatory Response

Despite these measures, isocyanate asthma remains the leading cause of occupational asthma in Europe. Why?

1. Substitution lag: Safer alternatives are not always adopted
2. Enforcement gaps: Small contractors may not comply with regulations
3. Economic pressure: Cost concerns delay substitution
4. Awareness gaps: Workers may not recognize early symptoms
5. Individual susceptibility: Some sensitize despite controls

The US Parallel

The United States has experienced a similar pattern:

• Isocyanates are the most common chemical cause of occupational asthma
• Spray painters are among the highest-risk occupations
• NIOSH has issued multiple alerts and criteria documents
• OSHA maintains exposure limits but cases continue

The US has not experienced the same concentrated epidemic as Europe, likely due to different industrial practices and less comprehensive surveillance. But the underlying risk is identical.

The Government Facility Context

For government agencies managing indoor facilities, the European experience is directly relevant:

1. Office renovations: Indoor painting in occupied buildings
2. Healthcare facilities: Coating applications near patients
3. Schools: Renovation during academic terms
4. Courthouses and public buildings: Maintenance painting
5. Military facilities: Barracks, mess halls, administrative buildings

In each of these settings, indoor application of isocyanate-containing coatings creates the same risk profile that produced the European asthma epidemic.

Powder Coating: Avoiding the Epidemic

Powder coatings contain no isocyanates and produce no solvent vapors. While powder coating is typically applied in dedicated booths with oven curing, the formulation itself eliminates the chemical hazards that drove the European asthma epidemic.

For indoor coating applications where powder coating is not feasible (e.g., on-site touch-up, field maintenance), water-based or low-VOC alternatives should be specified without isocyanate hardeners. The European experience demonstrates that the performance benefits of polyurethane systems are not worth the asthma risk when applied indoors.

Conclusion

The European isocyanate asthma epidemic was not an inevitable consequence of industrial progress. It was the predictable outcome of introducing reactive chemical coatings into indoor environments without adequate controls. Construction painters paid the price with their respiratory health.

For today's government specification writer, the European experience is both a warning and an opportunity. The warning: indoor application of isocyanate-containing coatings will cause occupational asthma. The opportunity: powder coating and other isocyanate-free alternatives eliminate this risk while delivering equivalent or superior performance. The choice is between repeating Europe's mistake and learning from it.